Bone marrow transplantation for hematologic malignancies: the Stanford experience.

Published

Journal Article

Allogeneic and autologous BMTs are highly effective and successful treatment modalities for selected patients. Use of BMT earlier in the course of disease yields better results when compared to patients with more advanced disease. Recent advances such as use of cloned growth factors, cytokines, etc..., will continue to contribute to lessen morbidity and mortality. Finally, as investigators understand, prevent, and treat expected side effects from BMTs, the patients' burden in terms of physical, psychological, and financial costs should lessen substantially.

Full Text

Duke Authors

Cited Authors

  • Chao, NJ; Amylon, MD; Long, GD; Negrin, RS; Hoppe, RT; Horning, SJ; Blume, KG

Published Date

  • 1990

Published In

Start / End Page

  • 157 - 163

PubMed ID

  • 2103141

Pubmed Central ID

  • 2103141

International Standard Serial Number (ISSN)

  • 0890-9016

Language

  • eng

Conference Location

  • United States